Nuvation Bio Wins US FDA Approval for Non-Small Cell Lung Cancer Drug Ibtrozi-February 2024-www.financetom.com

Nuvation Bio Wins US FDA Approval for Non-Small Cell Lung Cancer Drug Ibtrozi

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nuvation Bio Wins US FDA Approval for Non-Small Cell Lung Cancer Drug Ibtrozi

Jun 11, 2025 11:08 AM

01:47 PM EDT, 06/11/2025 (MT Newswires) -- Nuvation Bio ( NUVB ) said the US Food and Drug Administration approved Ibtrozi for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer in adult patients.

The approval is backed by data from the global clinical trial program showing high, durable response rates and brain-penetrant efficacy across different lines of treatment, the company said Wednesday in a statement.

Shares of the company fell 8.8% following a trading halt.

Price: 2.31, Change: -0.11, Percent Change: -8.77

Previous page： US Supreme Court urged to block Mississippi law restricting children's social media use Next page： Core & Main Insider Sold Shares Worth $1,480,094, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US Supreme Court urged to block Mississippi law restricting children's social media use

Jul 21, 2025

July 21 (Reuters) - An internet trade association whose members include Facebook, YouTube and Snapchat asked the U.S. Supreme Court on Monday to block a Mississippi law that imposes age-verification and parental-consent requirements on social media sites. Washington, D.C.-based NetChoice said in its filing that a 5th U.S. Circuit Court of Appeals panel improperly allowed the Mississippi law to take...

Core & Main Insider Sold Shares Worth $1,480,094, According to a Recent SEC Filing

Jul 21, 2025

05:41 PM EDT, 07/21/2025 (MT Newswires) -- Orvin T Kimbrough, Director, on July 18, 2025, sold 23,962 shares in Core & Main ( CNM ) for $1,480,094. Following the Form 4 filing with the SEC, Kimbrough has control over a total of 13,958 Class A common shares of the company, with 13,958 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1856525/000185652525000152/xslF345X05/wk-form4_1753133916.xml ...

Alexandria Real Estate reports upbeat quarterly FFO on resilient demand

Jul 21, 2025

July 21 (Reuters) - Alexandria Real Estate Equities ( ARE ) reported second-quarter funds from operations above analysts' estimates on Monday, driven by a recovery in leasing demand. The real estate investment trust (REIT), which owns, operates and develops life science laboratories, offices and technology campuses across North America, benefited from improved leasing during the quarter, supported by increased funding...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...